Vinati Organics keeps FY27 growth guidance despite Viral delay
In short
Vinati Organics kept its FY27 guidance for 15% volume growth and 26-27% EBITDA margins. The company said the turnaround at Viral Organics has been delayed by one quarter, but it still expects that unit to become profitable in FY28.
This matters because the company says exports, core product demand and antioxidants growth should support results. The reporting does not say how much the delay will change earnings.
What the reporting says
Vinati Organics has retained its FY27 guidance of 15% volume growth and 26-27% EBITDA margins, even after delaying the Viral Organics turnaround by a quarter, according to its managing director. Vinati Saraf Mutreja said Viral Organics is now expected to turn profitable in FY28, while weaker rupee-driven export realisations, improving demand in core products and 30% growth in antioxidants are supporting the outlook. The exact financial impact of the delay is not stated.
Why it matters
Vinati Organics has kept its FY27 target of 15% volume growth and 26-27% EBITDA margins despite pushing back the Viral Organics turnaround by one quarter. Managing Director Vinati Saraf Mutreja said Viral Organics should turn profitable in FY28, supported by stronger export realisations from a weaker rupee, improving core-product demand and 30% growth in antioxidants. The reporting does not quantify the delay’s total impact.